 Administration, Ophthalmic
"Administration, Ophthalmic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Application of pharmaceutically active agents on the tissues of the EYE.
| Descriptor ID |
D060433
|
| MeSH Number(s) |
E02.319.267.120.805
|
| Concept/Terms |
Administration, Ophthalmic- Administration, Ophthalmic
- Administrations, Ophthalmic
- Ophthalmic Administration
- Ophthalmic Administrations
- Ocular Administration
- Administration, Ocular
- Administrations, Ocular
- Ocular Administrations
|
Below are MeSH descriptors whose meaning is more general than "Administration, Ophthalmic".
Below are MeSH descriptors whose meaning is more specific than "Administration, Ophthalmic".
This graph shows the total number of publications written about "Administration, Ophthalmic" by people in this website by year, and whether "Administration, Ophthalmic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 | | 2011 | 0 | 2 | 2 | | 2013 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2018 | 0 | 1 | 1 | | 2019 | 0 | 2 | 2 | | 2020 | 0 | 1 | 1 | | 2021 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Ophthalmic" by people in Profiles.
-
Gaballa SA, Kompella UB, Elgarhy O, Alqahtani AM, Pierscionek B, Alany RG, Abdelkader H. Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives. Drug Deliv Transl Res. 2021 06; 11(3):866-893.
-
Liu Z, Kompella UB, Chauhan A. Gold nanoparticle synthesis in contact lenses for drug-less ocular cystinosis treatment. Eur J Pharm Biopharm. 2021 Aug; 165:271-278.
-
Edwards RG, Vanderhoof S, Palestine A, Seibold LK. Bilateral Secondary Angle Closure During Daratumumab Infusion: A Case Report and Review of the Literature. J Glaucoma. 2020 08; 29(8):e83-e86.
-
Kompella UB, Domb A, Urtti A, Jayagopal A, Wilson CG, Tang-Liu D. ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery. J Ocul Pharmacol Ther. 2019 10; 35(8):457-465.
-
Kahook MY, Serle JB, Mah FS, Kim T, Raizman MB, Heah T, Ramirez-Davis N, Kopczynski CC, Usner DW, Novack GD. Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2). Am J Ophthalmol. 2019 04; 200:130-137.
-
Srinivas SP, Goyal A, Talele DP, Mahadik S, Sudhir RR, Murthy PP, Ranganath S, Kompella UB, Padmanabhan P. Corneal epithelial permeability to fluorescein in humans by a multi-drop method. PLoS One. 2018; 13(6):e0198831.
-
Hartman RR, Kompella UB. Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery. J Ocul Pharmacol Ther. 2018 Jan/Feb; 34(1-2):141-153.
-
Kompella UB. Nanotechnology and drug delivery. J Ocul Pharmacol Ther. 2013 Mar; 29(2):89.
-
Thakur A, Scheinman RI, Rao VR, Kompella UB. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res. 2011 Nov; 82(3):346-50.
-
Rolando M, Crider JY, Kahook MY. Ophthalmic preservatives: focus on polyquaternium-1. Expert Opin Drug Deliv. 2011 Nov; 8(11):1425-38.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|